Moreover, miR-135a promoted the proliferation and invasion of oxaliplatin-resistant gastric cancer cells, and inhibited E2F transcription factor 1 (E2F1) induced apoptosis by inhibiting E2F1 and DAPK2 expression (Yan et al., 2016b). The gene discussed is E2F1; the disease is gastric cancer.